Skip to main content

Featured

Trump Files $10 Billion Lawsuit Over IRS Tax Leak

US President Donald Trump and his sons Eric Trump, left, and Donald Trump Jr, right, have sued the US federal government over tax leaks.  A new legal battle has erupted as President Donald Trump launches a sweeping $10 billion lawsuit against the U.S. government, accusing federal agencies of failing to protect his confidential tax information. The suit targets both the IRS and the Treasury Department, alleging that years of his private financial records were improperly accessed and leaked to media outlets he describes as politically hostile. The complaint argues that the unauthorized disclosure caused significant damage to Trump’s reputation, business interests, and public standing. It also claims that the leak stemmed from a politically motivated insider who exploited access to sensitive IRS systems. That individual has since been convicted, but Trump maintains that the government bears responsibility for allowing the breach to occur in the first place. The lawsuit, filed in fe...
Post a Comment
Read more

article

Labels

Alzheimer’s vaccines get a boost from new drug approval

 

After decades of disappointment and controversy, the field of Alzheimer’s disease research has finally seen a breakthrough with the approval of the first drug that targets the underlying pathology of the condition. 

Aducanumab, a monoclonal antibody that clears amyloid plaques from the brain, was granted accelerated approval by the US Food and Drug Administration in June 2021, despite mixed results from clinical trials and objections from some experts. 

The drug’s approval has rekindled interest in other therapeutic approaches that aim to prevent or slow down the progression of Alzheimer’s, such as vaccines that stimulate the immune system to attack amyloid or tau, another protein that accumulates in the brains of people with the disease. 

Several vaccine candidates are currently in various stages of development and testing, and some researchers are optimistic that they could offer a more effective and convenient way to treat Alzheimer’s than infusions of antibodies.


Labels:

Comments

Post a Comment